Inauguration Ceremony

Inauguration Ceremony of the New Filling Line at the Takeda Manufacturing Site in Neuchâtel

The new facility has been constructed using the most advanced technologies in the industry and with a higher level of automation including a strong focus on data and digital technologies. Our strategic investments of CHF 200 million will significantly enhance production capacity to better meet unmet medical needs and better serve patients with rare diseases.

We are looking forward to celebrating this important milestone with you, alongside Federal Councilor Guy Parmelin, representatives from the canton and city of Neuchâtel as well as members of our Executive Team.

November 26, 2025

Registration

Takeda aims to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet.
Entering the Swiss market in 1986, Takeda is the fifth largest biotechnology company in Switzerland today. With 1,900 employees, of which approximately 700 are working at our production site in Neuchâtel, we are serving patients in over 80 countries. At the facility, we manufacture life-transforming treatments for patients with rare diseases. The site will celebrate its 30th anniversary in 2026. For more information, visit www.takeda.com.

Inauguration Ceremony

Registration

Location

Schedule

Speakers

Images